New nerve block may slash morphine use after lung surgery
NCT ID NCT07335250
First seen Jun 27, 2026 · Last updated Sep 10, 2026 · Updated 4 times
Summary
This study tests whether a special nerve block (intertransverse process block) can reduce pain and the need for morphine after lung surgery. About 66 adults having a planned lung lobe removal will be randomly assigned to get either the nerve block or a placebo. The goal is to see if this block provides better pain control and lowers opioid use in the first 24 hours after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
66 people
The number who actually took part.
- Started
-
Apr 2026
- Finished
-
Sep 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Provision of written informed consent Age between 18 and 85 years ASA Physical Status classification I-III Elective thoracotomy with planned unilateral lobectomy Anticipated hospital stay of at least one night Expected requirement for parenteral opioid analgesia for at least 24 hours postoperatively Ability to operate an intravenous patient-controlled analgesia (PCA) device Exclusion Criteria: * Patients undergoing emergency surgery Presence of infection or open wound at the injection site Coagulopathy Hepatic or renal failure Patients undergoing reoperation Patients with missing or incomplete data Pregnancy or lactation Tracheal malformation or tracheostomy Chronic opioid use (≥30 days within the last 3 months, ≥15 mg/day morphine equivalent) Patients exceeding the maximum safe local anesthetic dose based on weight (2.5 mg/kg, max 150 mg) Patients who refuse data privacy consent will be excluded from the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute postoperative pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Konya City Hospital
Konya, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One 2-Hour class may help new mothers manage Post-Cesarean pain
- Your genes may decide if a Post-Surgery pain pump works
- Can a pain score guide better Post-Surgery pain relief?
- Which nerve block eases chest surgery pain better?
- One injection or many? a test to ease breast surgery pain
- Can a gentle electric zap ease pain after chest surgery?